Grants for Researchers

National Institutes of Health · Amount varies

This NIH (NICHD) P20 exploratory grant funds NExT AI Hubs studying how artificial intelligence technologies affect children diagnosed with or at risk for specific learning disabilities in reading, writing, and mathematics. Foreign organizations and foreign components are not eligible to apply; refer to the NOFO's eligibility section for the full list of eligible domestic applicants. A clinical trial is optional. No specific award amount is stated, and the program emphasizes building research infrastructure and early-career investigators.

National Institutes of Health · Up to $800K

This NIH (NICHD) P50 award funds Intellectual and Developmental Disabilities Research Centers. It is a limited competition: only current recipients of IDDRC P50 awards under RFA-HD-20-016 or RFA-HD-21-009 are eligible to apply, so new applicants do not qualify. Foreign organizations and foreign components are not eligible. A clinical trial is optional, and the stated maximum is about $800,000 for centers running three years.

National Institutes of Health · Amount varies

This NIH (NIDCD) award funds Clinical Research Center Grants (P50) advancing diagnosis, prevention, and treatment of hearing, balance, smell, taste, voice, speech, or language disorders. Eligible applicants are domestic research-capable organizations, including higher-education institutions, nonprofits, tribal governments, faith-based or community organizations, and U.S. territories; foreign organizations are not eligible to apply, though foreign components may be allowed. A low-risk clinical trial is optional, not required. No dollar range is stated, and applicants should read the NOFO closely and contact NIDCD staff before applying.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Peer Reviewed Cancer Research Program Impact Award supports mature research with near-term potential to affect clinical cancer care within congressionally directed FY26 topic areas. Eligibility is described as unrestricted (open to any entity type), subject to clarifications. Applications must include preliminary data supporting feasibility; clinical trials are allowed. Up to two partnering Principal Investigators are permitted. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Peer Reviewed Cancer Research Program Idea Award supports innovative, untested, high-risk/high-reward concepts and basic cancer research relevant to the Military Health System. Eligibility is described as unrestricted (open to any entity type), subject to clarifications. Preliminary data are not required, but a strong scientific rationale is. A new Early Career Investigator option supports promising investigators early in faculty appointments. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Peer Reviewed Cancer Research Program Clinical Trial Award funds clinical trials (phase 0 through phase III) testing new products, drugs, devices, or approaches to treat or manage cancer within designated topic areas. Applications must include a clinical trial and patient advocates, animal studies are not allowed, and any required IND/IDE regulatory application must be submitted by the application deadline. Eligibility is described as unrestricted (open to any standard entity type), subject to clarification in the program announcement. No specific award amount is stated in this record.

National Institutes of Health · Amount varies

This NIH R01 funds research examining the efficacy and clinical effectiveness of digital health technologies for the remote management of type 2 diabetes; a clinical trial is required. Eligible applicants include federal agencies, tribal governments, faith- or community-based organizations, regional organizations, and U.S. territories, in addition to standard research institutions. Foreign organizations and the foreign components of U.S. organizations are not eligible, and foreign components are not allowed. No specific award amount is stated in this record; see the NOFO for full eligibility details.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Pancreatic Cancer Research Program Focused Pilot Award supports exploratory, innovative pancreatic cancer research intended to produce preliminary data for future work; preliminary data are allowed but not required. Clinical research studies are permitted, but clinical trials are not allowed and preclinical animal-only studies do not meet the intent. Eligibility is described as unrestricted (open to any standard entity type), subject to clarification in the program announcement. No specific award amount is stated in this record.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Pancreatic Cancer Research Program Idea Development Award funds innovative, high-risk/high-reward pancreatic cancer research; preliminary data relevant to the project are required. Clinical research studies are allowed, but clinical trials are not. Eligibility is described as unrestricted (open to any standard entity type), subject to clarification in the program announcement. An optional partnering mechanism offers higher funding to pair an experienced PI with an early-career investigator. No specific award amount is stated in this record.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Pancreatic Cancer Research Program Translational Research Partnership Award funds partnerships among clinicians, population, applied, and/or basic scientists to move promising pancreatic cancer ideas toward clinical application, and requires two Principal Investigators (an initiating and a partnering PI) with at least one having pancreatic cancer expertise. Preliminary data are required; pilot clinical trials and retrospective/correlative studies are allowed, but large-scale clinical trials are not. Eligibility is described as unrestricted (open to any standard entity type), subject to clarification in the program announcement. No specific award amount is stated.

U.S. National Science Foundation · $500K–$1.5M

This NSF program funds research collaborations on the mathematical and theoretical foundations of AI and machine learning. Proposals may only be submitted by U.S. institutions of higher education (including community colleges) and U.S. non-profit, non-academic research organizations such as independent research laboratories and professional societies. The PI must hold a tenured/tenure-track position or a full-time paid research or teaching appointment; individuals at for-profit organizations or overseas branch campuses are not eligible. Awards range from about $500,000 to $1,500,000.

National Institutes of Health · Up to $1M

This NIH (NIDDK) U01 cooperative agreement funds clinical centers to join a consortium testing anti-obesity medication treatment strategies for children and adolescents with obesity. A clinical trial is required, and as a cooperative agreement NIH staff are substantially involved; applicants are typically clinical research institutions. Foreign organizations, the foreign components of U.S. organizations, and foreign components generally are not eligible or allowed. Stated funding is up to about $1,000,000; consult the NOFO for full eligibility details.

U.S. National Science Foundation · Amount varies

This NSF Algebra and Number Theory program supports research in algebra, algebraic and arithmetic geometry, number theory, and representation theory, and also funds conferences, workshops, and summer/winter schools. Eligibility is described as unrestricted (open to any standard NSF entity type), subject to clarification in the NOFO, though proposals are typically led by universities and research organizations. Conference proposals follow specific submission windows depending on budget size. No specific award amount is stated in this record.

National Institutes of Health · Amount varies

This NIH (NIDDK) U24 cooperative agreement funds a single Research Coordinating Center to manage data, statistics, and operations for a consortium testing anti-obesity medication strategies in children and adolescents. Clinical trials are not allowed under this center role, and as a cooperative agreement NIH staff are substantially involved; this is a specialized coordinating-center award rather than a broad research grant. Foreign organizations, the foreign components of U.S. organizations, and foreign components are not eligible or allowed. No specific award amount is stated; see the NOFO for full eligibility details.

National Institutes of Health · Amount varies

This NIH R01 supports research institutions and investigators studying how to design rigorous clinical trials of rapid-acting psychotropic drugs (RAPIDs) and adjunctive psychosocial interventions. A clinical trial is required, so applicants must be prepared to run one. Foreign (non-U.S.) organizations, foreign components of U.S. organizations, and foreign components generally are not eligible or allowed. The notice does not state an award ceiling; refer to the NOFO for eligibility and budget details.

U.S. National Science Foundation · Amount varies

This NSF Mathematical Biology program supports research across the mathematical sciences with relevance to biology, requiring strong integration of mathematical innovation and biological significance. Eligibility is described as unrestricted (open to any standard NSF entity type) subject to clarification in the NOFO, so a broad range of research organizations such as universities may apply; in practice proposals are typically led by institutions of higher education. The program also supports conferences and special proposal types (EAGER, RAPID, RUI). No specific award amount is stated in this record.

National Institutes of Health · Amount varies

This NIH (NCI) K99/R00 is a career-transition award for early-stage postdoctoral cancer researchers moving toward independent faculty positions; in this version the candidate may not lead an independent clinical trial (companion NOFOs cover those who will). It is applied for through a host institution such as a university, so eligibility centers on higher-education and research institutions rather than individuals on their own. Foreign institutions and the foreign components of U.S. organizations are not eligible to apply, though some foreign components are allowed. No award ceiling is stated in this record.

National Institutes of Health · Up to $250K

This NIH (NCI) UH3 award funds the clinical validation of already analytically validated molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response, using specimens from clinical trials or studies. Eligible applicants include higher-education institutions, nonprofits, tribal governments, and federal agencies; clinical trials are not allowed and early-stage technology development is out of scope. Applicants must already have an analytically validated assay, which narrows who can realistically apply. Foreign organizations and foreign components of U.S. organizations are not eligible to apply; stated funding is around $250,000.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Melanoma Research Program Survivorship Research Award funds research aimed at improving the health and well-being of melanoma survivors, their families, and care partners, with clinical trials allowed. Eligibility is described as unrestricted (open to any standard entity type), subject to clarification in the program announcement. Note one requirement: each application must include at least one melanoma consumer collaborator (a survivor, family member, care partner, or supporting organization). Animal-model-only or survival-only studies are not responsive. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Melanoma Research Program Focused Program Award (Rare Melanomas) funds a multidisciplinary program of two to three complementary projects addressing rare melanomas, and requires partnering Principal Investigators (an initiating PI plus one or two partnering PIs) plus at least one rare melanoma survivor or patient advocate on the team. Eligibility is described as unrestricted (open to any standard entity type), subject to clarification in the program announcement. A pre-application is required, and only invited applicants may submit a full application; clinical trials are allowed. No specific award amount is stated.